Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Otovel® (ciprofloxacin/fluocinolone) – First-time authorized brand alternative (ABA)
October 30, 2019 - Wilshire Pharmaceuticals launched an authorized brand alternative of Laboratorios Salvat/Arbor’s Otovel (ciprofloxacin/fluocinolone) otic solution.